News

University of Manchester scientists investigating a possible treatment for fetal growth restriction (FGR), a condition in which babies grow poorly in the womb, have urged further caution on the use of Viagra.

Scientists have shown that cells from children with NGLY1 deficiency--a rare disorder first described in 2012--lack sufficient water channel proteins called aquaporins. The discovery may help explain the disorder's wide-ranging symptoms--including the inability to produce tears, seizures and developmental delays--and opens new avenues to find therapies to treat the disorder.

New research published in Nature suggests that B cells also play a major role in predicting of patient’s response to immunotherapy, whilst it was previously thought only T cells could be used in this way.

Yale researchers have discovered a novel way to evade the brain’s natural defenses by slipping immune system “rescuers” through its drainage system.

Researchers have engineered and tested a new therapeutic nanoparticle platform to deliver the drug paclitaxel to treat triple-negative breast cancer.

Researchers report in the journal Nature that they have for the first time demonstrated at the molecular level what happens when two antimalarial drugs were combined.

Researchers from University of Minnesota Medical School have discovered a novel potential target for treating drug addiction through astrocytes which they refer to as “the hidden stars of the brain.”

In a new research study published in the journal Science Advances, scientists from the University of Liverpool sought to identify specific genes that are associated with high levels of alcohol consumption.

Researchers have shown the therapeutic efficacy of a new experimental drug in mouse models of Alzheimer’s disease and a rare genetic form of epilepsy known as Dravet syndrome.

An injectable, biomaterial-based vaccine, when combined with standard chemotherapy, resulted in the complete and lasting recovery from, and immunity against, the deadly blood cancer acute myeloid leukemia (AML) in mice.